Webinar: Advances in Gene Editing Technologies
Tuesday 6th September | 2pm GMT
Hosted by Richard Morgan, Vice President, Immunotherapy at Bluebird Bio:
• Introduction to the major gene editing platforms
• Potential target genes for editing
• Cellular engineering technologies
• Combining gene editing and immunotherapy
• Scale up and commercial issues
Register today, for free: https://attendee.gotowebinar.com/register/2672748214231672067
Benefits to Attending:
• Hear more about the latest updates in gene editing technologies
• Learn more about enhancing immunotherapy through the use of gene editing
• Discussions of accelerating processes with accuracy and efficiency
Webinar: Advances in the Characterisation of Stem Cells and the Non-IPSC Approach for Diabetes
Thursday, 8th September 2016 | 2pm GMT
Speaker 1: Nagy Habib, Professor of Hepatobiliary Surgery, Imperial College of London: The non-IPSC approach for diabetes
In this session, we will explore:
• Mechanism of RNA activation with Oligonucleotides
• Conversion of CD34+ into glucose sensitive insulin producing cells
• RNA liver activation effect on Type 2 Diabetes
Speaker 2: Davide Danovi, Director HipSci Cell Phenotyping, Kings’s College London: Using High Content Analysis to Characterise Stem Cells
• The human induced pluripotent stem cells initiative, a resource for the scientific community
• Characterisation of large panels of stem cells using high content image analysis
• Collaborative phenotype screening strategies for academia and industry
Register today, for free: https://attendee.gotowebinar.com/register/8738552655680973571
Benefits to Attending:
• Advance your knowledge the non-IPSC approach for diabetes
• Discuss the challenges associated with using high content analysis to characterise stem cells
• Hear about RNA liver activation
• Gain an overview about the derivation, manipulation and characterisation of iPSCs